Glypican‐3 protein expression in primary and metastatic melanoma
Open Access
- 10 June 2009
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 117 (4), 271-278
- https://doi.org/10.1002/cncy.20032
Abstract
BACKGROUND: The incidence of melanoma is increasing. Fine-needle aspiration (FNA) is critical in documenting recurrent/metastatic disease in established cases. The potential of metastatic melanoma (MM) to mimic epithelial tumors presents a diagnostic dilemma. In liver FNA, the distinction between hepatocellular carcinoma (HCC) and MM is a frequent challenge. Glypican-3 (GPC3), a heparan sulfate proteoglycan, is a highly sensitive and specific marker for HCC. Serum GPC3 was shown to be expressed in 40% of primary melanomas (PMs), but to the authors' knowledge no tissue studies to date have assessed GPC3 expression in MM. In this study, GPC3 protein expression was investigated in FNAs from MM, and in corresponding histologic sections from the primary tumors. METHODS: Sixty archival, direct FNA smears or CytoLyt-fixed samples from 50 patients with MM were retrieved together with formalin-fixed, paraffin-embedded specimens available from 17 corresponding PMs. All cases were stained with anti-GPC3 antibody. FNA and core biopsy specimens from HCCs and benign liver were used as positive and negative controls. GPC3 expression was divided into 2 categories: negative (negative or weak cytoplasmic staining) and positive (moderate or strong cytoplasmic with membranous accentuation). RESULTS: All FNAs from MM cases were negative (0 of 60) for GPC3. The exact 95% Clopper-Pearson confidence interval was 0.0% to 5.96%. Only 1 case of PM (1 of 17; 5.9%) demonstrated weak focal cytoplasmic staining (regarded as negative). CONCLUSIONS: In the current study, all MM and PM cases in archival FNAs and tissue sections were found to be negative for GPC3. These data suggest that GPC3 is not expressed in melanoma using the 1G12 clone. Cancer (Cancer Cytopathol) 2009. © 2009 American Cancer Society.Keywords
This publication has 33 references indexed in Scilit:
- State of the science 60th anniversary reviewCancer, 2008
- Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinomaLaboratory Investigation, 2008
- Glypican‐3 immunohistochemistry in the ovaryHistopathology, 2008
- Glypican-3 immunocytochemistry in liver fine-needle aspiratesCancer, 2007
- Glypican-3 Expression in Primary and Recurrent Ovarian CarcinomasInternational Journal of Gynecological Pathology, 2007
- Diagnosis of Metastatic Melanoma by Fine-Needle BiopsyAmerican Journal of Clinical Pathology, 2007
- Identification of Glypican-3 as a Novel Tumor Marker for MelanomaClinical Cancer Research, 2004
- Metastatic malignant melanoma in liver aspirate: Cytomorphologic distinction from hepatocellular carcinomaDiagnostic Cytopathology, 2004
- Cytomorphologic features of fine‐needle aspiration of metastatic and recurrent melanomaDiagnostic Cytopathology, 2002
- Fine Needle Aspiration Cytology and Immunocytochemistry of Metastatic MelanomaCytopathology, 1991